Mednax, Inc. (MD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Mednax, Inc. (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. It offers its services through its two divisions, namely, Pediatrix Medical Group (Pediatrix) and American Anesthesiology, Inc. Its Pediatrix division is one of the the nation's largest provider of newborn hearing screens, and includes a network of neonatal physicians offering services to more than 340 neonatal intensive care units (NICUs). The American Anesthesiology, Inc. includes anesthesiologists and advanced practitioners to provide anesthesia care. The company through its affiliated professional corporations has presence in 34 states and Puerto Rico. Mednax is headquartered in Sunrise, Florida, the US.
Mednax, Inc. Key Recent Developments
Jan 29, 2015: MEDNAX Reports Double-Digit Fourth Quarter 2014 Revenue and EPS Growth Nov 26, 2013: Mednax to present at the 25th annual Piper Jaffray Healthcare Conference in New York City Sep 05, 2013: MEDNAX to Present at the Stifel Healthcare Conference 2013 in Boston Jan 31, 2013: Mednax Reports Revenue Of $1.8 Billion In 2012
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
Mednax, Inc. (MD) - Financial and Strategic SWOT Analysis Review Table of Contents Section 1 - About the Company 6 Mednax, Inc. - Key Facts 6 Mednax, Inc. - Key Employees 7 Mednax, Inc. - Key Employee Biographies 9 Mednax, Inc. - Major Products and Services 10 Mednax, Inc. - History 11 Mednax, Inc. - Company Statement 15 Mednax, Inc. - Locations And Subsidiaries 17 Head Office 17 Other Locations and Subsidiaries 17 Section 2 - Company Analysis 18 Mednax, Inc. - Business Description 18 Mednax, Inc. - Corporate Strategy 19 Mednax, Inc. - SWOT Analysis 20 SWOT Analysis - Overview 20 Mednax, Inc. - Strengths 20 Strength - Integrated Network of Affiliated Physicians 20 Strength - Increased Revenue 20 Strength - Market Leading Position 20 Mednax, Inc. - Weaknesses 21 Weakness - Revenue Concentration 21 Weakness - Increasing Trade Receivables 21 Weakness - Debt Obligations 21 Mednax, Inc. - Opportunities 22 Opportunity - Strategic Acquisitions 22 Opportunity - Increased Demand for Physician Services 22 Opportunity - Rising Healthcare Expenditure in the US 22 Mednax, Inc. - Threats 23 Threat - Competitive Environment 23 Threat - Stringent Government Regulations 23 Threat - Data Security and Privacy Concerns 23 Mednax, Inc. - Key Competitors 24 Section 3 - Company Financial Ratios 25 Financial Ratios - Capital Market Ratios 25 Financial Ratios - Annual Ratios 26 Performance Chart 27 Financial Performance 27 Financial Ratios - Interim Ratios 28 Financial Ratios - Ratio Charts 29 Section 4 - Company's Lifesciences Financial Deals and Alliances 30 Mednax, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 30 Mednax, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 31 Mednax, Inc., Recent Deals Summary 32 Section 5 - Company's Recent Developments 33 Jan 29, 2015: MEDNAX Reports Double-Digit Fourth Quarter 2014 Revenue and EPS Growth 33 May 12, 2014: MEDNAX Announces Data Milestone for Pediatrix Division 35 Jan 30, 2014: MEDNAX Earns $0.78 Per Share for 2013 Fourth Quarter 36 Section 6 - Appendix 38 Methodology 38 Ratio Definitions 38 About GlobalData 42 Contact Us 42 Disclaimer 42
List of Tables
Mednax, Inc., Key Facts 6 Mednax, Inc., Key Employees 7 Mednax, Inc., Key Employee Biographies 9 Mednax, Inc., Major Products and Services 10 Mednax, Inc., History 11 Mednax, Inc., Subsidiaries 17 Mednax, Inc., Key Competitors 24 Mednax, Inc., Ratios based on current share price 25 Mednax, Inc., Annual Ratios 26 Mednax, Inc., Interim Ratios 28 Mednax, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 30 Mednax, Inc., Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 31 Mednax, Inc., Recent Deals Summary 32 Currency Codes 38 Capital Market Ratios 38 Equity Ratios 39 Profitability Ratios 39 Cost Ratios 40 Liquidity Ratios 40 Leverage Ratios 41 Efficiency Ratios 41
List of Figures
Mednax, Inc., Performance Chart (2010 - 2014) 27 Mednax, Inc., Ratio Charts 29 Mednax, Inc., Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 30 Mednax, Inc., Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 31